NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
35 hedge funds and large institutions have $1.13M invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
89% less capital invested
Capital invested by funds: $10.7M → $1.13M (-$9.59M)
Holders
35
Holding in Top 10
–
Calls
$11K
Puts
$33K
Top Buyers
| 1 | +$65.3K | |
| 2 | +$28K | |
| 3 | +$22K | |
| 4 |
Renaissance Technologies
New York
|
+$20.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$14K |
Top Sellers
| 1 | -$915K | |
| 2 | -$161K | |
| 3 | -$125K | |
| 4 |
Neuberger Berman Group
New York
|
-$86K |
| 5 |
FPF
FNY Partners Fund
New York
|
-$74K |